GSK Pharma Q3 profit rises 7%

Agencies
Posted: Friday, Oct 30, 2009 at 1418 hrs IST
Updated: Friday, Oct 30, 2009 at 1418 hrs IST

Font Size

Feedback

Discuss

Dr Reddy's Q2 net up 3 fold at Rs 240 cr Piramal Healthcare Q2 net up 45 pct Ranbaxy hails US court ruling on Valcyte patent

New Delhi: GlaxoSmithKline Pharmaceuticals (GSK) reported a rise of 7 per cent in net profit to Rs 141.08 crore for the third quarter ended September 30.

The net sales of drug manufacturer grew by 12 per cent to Rs 511.81 crore in the latest quarter of current year from Rs 456.95 crore of the corresponding quarter a year earlier, GSK Pharma said in a filing to the Bombay Stock Exchange (BSE).

"The growth sales was impacted due to lower selling prices as a result of excise duty reduction being passed on to the consumer," the company said.

For the nine-month period ended September 30, 2009, the drug maker posted a net profit of Rs 408.70 crore, up 11 per cent as compared to Rs 368.10 crore of the same period a year ago.

Shares of GSK Pharma were trading at Rs 1,600, marginally down by 0.04 per cent in the afternoon trade on the BSE.

Post Comments

Comments: (Limit 3,000 characters)

Name		Message
Email ID
Subject

TERMS OF USE:
The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).

I agree to the terms of use.

Latest News

Print Edition

Events

GSK Pharma Q3 profit rises 7%

Post Comments